A study published in the Endocrine Journal showed some GLP-1 drugs have been linked to an increased risk of developing blood clots
The National Academy of Medicine provides guidance on total water intake, but a practical approach is to drink enough that urine remains pale yellow
ABSTRACT: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide/GLP-1 RAs are common therapies for managing diabetes and obesity, but gastrointestinal (GI) adverse effects (AEs) such as nausea, vomiting, diarrhea, and constipation frequently limit therapy
it means having more energy for your daily life
2) Real-world readiness: Pay attention to evidence on persistence, access, and health equity
Schlatter, P., Beglinger, C., Drewe, J